This tutorial gives an overview of Radioimmunotherapy
in Non Hodgkins Lymphoma
After completing this tutorial, attendees will be able
to:
- Name the two radiopharmaceuticals approved by the FDA for
performance of RIT Procedures
- Describe how patient- specific doses are determined and identify the
typical dose for each radiopharmaceutical
- List several eligibility criteria for undergoing the RIT procedure
- Name the pretreatment designed specifically for Bexxar
- Describe the special radiation safety considerations when
administering Bexxar to patients
- Briefly describe the results of clinical trials in the US for the
past 10 years
- List potential long-term effects that could result from this
treatment
|
